volume 42 issue 6 pages 582-587

Protective effects of the CB1 receptor agonist WIN 55.212-2 during development of seizure activity in the brain in models of temporal epilepsy in vivo

Publication typeJournal Article
Publication date2012-07-01
scimago Q4
SJR0.183
CiteScore0.7
Impact factor
ISSN00970549, 1573899X
General Neuroscience
Abstract
The effects of intracerebral intraventricular administration of the nonselective cannabinoid CB1 receptor WIN 55.212-2 (1 μM, 2 μl) on seizure activity were studied in conscious guinea pigs. Changes in local field potential and convulsive discharges evoked by electrical stimulation of the perforant path were recorded simultaneously in the hippocampus, entorhinal cortex, medial septal area, and amygdala after prior administration of WIN 55.212-2 or the organic solvent DMSO. In 80% of tests, WIN 55.212-2 was found to block the development of seizure activity. Repeated injections of agonist for 30 days increased the amplitude of local field potentials and the power of the theta rhythm in all structures recorded. Administration of kainic acid provoked status epilepticus in control animals, while status epilepticus did not arise in guinea pigs given daily agonist injections for 25–30 days. The possible mechanisms of the protective effects of WIN 55.212-2 are discussed.
Found 
Found 

Top-30

Journals

1
2
Epilepsy Research
2 publications, 66.67%
Brain Research
1 publication, 33.33%
1
2

Publishers

1
2
3
Elsevier
3 publications, 100%
1
2
3
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
3
Share
Cite this
GOST |
Cite this
GOST Copy
Shubina L. V., Kichigina V. F. Protective effects of the CB1 receptor agonist WIN 55.212-2 during development of seizure activity in the brain in models of temporal epilepsy in vivo // Neuroscience and Behavioral Physiology. 2012. Vol. 42. No. 6. pp. 582-587.
GOST all authors (up to 50) Copy
Shubina L. V., Kichigina V. F. Protective effects of the CB1 receptor agonist WIN 55.212-2 during development of seizure activity in the brain in models of temporal epilepsy in vivo // Neuroscience and Behavioral Physiology. 2012. Vol. 42. No. 6. pp. 582-587.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s11055-012-9604-0
UR - https://doi.org/10.1007/s11055-012-9604-0
TI - Protective effects of the CB1 receptor agonist WIN 55.212-2 during development of seizure activity in the brain in models of temporal epilepsy in vivo
T2 - Neuroscience and Behavioral Physiology
AU - Shubina, L. V.
AU - Kichigina, V F
PY - 2012
DA - 2012/07/01
PB - Springer Nature
SP - 582-587
IS - 6
VL - 42
SN - 0097-0549
SN - 1573-899X
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2012_Shubina,
author = {L. V. Shubina and V F Kichigina},
title = {Protective effects of the CB1 receptor agonist WIN 55.212-2 during development of seizure activity in the brain in models of temporal epilepsy in vivo},
journal = {Neuroscience and Behavioral Physiology},
year = {2012},
volume = {42},
publisher = {Springer Nature},
month = {jul},
url = {https://doi.org/10.1007/s11055-012-9604-0},
number = {6},
pages = {582--587},
doi = {10.1007/s11055-012-9604-0}
}
MLA
Cite this
MLA Copy
Shubina, L. V., et al. “Protective effects of the CB1 receptor agonist WIN 55.212-2 during development of seizure activity in the brain in models of temporal epilepsy in vivo.” Neuroscience and Behavioral Physiology, vol. 42, no. 6, Jul. 2012, pp. 582-587. https://doi.org/10.1007/s11055-012-9604-0.